Aclaris Therapeutics, Inc. (ACRS) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.53 | +69.0% |
| 2024 | $-1.71 | -34.6% |
| 2023 | $-1.27 | +4.5% |
| 2022 | $-1.33 | +16.9% |
| 2021 | $-1.60 | -33.3% |
| 2020 | $-1.20 | +69.2% |
| 2019 | $-3.90 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.53 | +69.0% |
| 2024 | $-1.71 | -34.6% |
| 2023 | $-1.27 | +4.5% |
| 2022 | $-1.33 | +16.9% |
| 2021 | $-1.60 | -33.3% |
| 2020 | $-1.20 | +69.2% |
| 2019 | $-3.90 | — |